6 results for "Steven D. Colquhoun"
Showing 1–6 · 0.09 seconds · RSS
-
Journal Article
Neuroendocrine tumors with hepatic metastases: A review of evolving treatment options
Once considered exceptionally rare, neuroendocrine tumors (NET) are increasingly common and therefore of growing relevance to both clinicians and researchers. Most patients with such tumors present with symptoms, and, of those, 90% have secondary liver involvement. In the recent past, individuals…
-
Journal Article
Hepatocellular carcinoma clinical update: Current standards and therapeutic strategies
Hepatocellular carcinoma (HCC) accounts for the vast majority of primary hepatic malignancies. The overall incidence of this disease has always been significant, but in recent years it has continued to rise, now making HCC one of the leading causes of cancer deaths worldwide. Fortunately, research…
-
Journal Article
Hepatocellular carcinoma immunotherapy: The impact of epigenetic drugs and the gut microbiome
The incidence of hepatocellular carcinoma (HCC) has been increasing for decades. This disease has now risen to become the sixth most common malignancy overall, while ranking as the third most frequent cause of cancer mortality. While several surgical interventions and loco-regional treatment…
-
Journal Article
Overexpression of Galectin-1 and Galectin-3 in hepatocellular carcinoma
Galectins (Gals) are evolutionarily conserved proteins that bind to β-galactoside containing glycans. Abnormal expression of Gals is associated with the development, progression, and metastasis of different types of cancer. Among the 11 Gals identified in humans, the roles of Gal-1 and Gal-3 have…
-
Journal Article
Milan Criteria and UCSF Criteria: A Preliminary Comparative Study of Liver Transplantation Outcomes in the United States
The application of orthotopic liver transplantation (OLT) for patients with hepatocellular cancer (HCC) necessitates highly selective criteria to maximize survival and to optimize allocation of a scarce resource. The objective of this study was to compare the outcomes of OLT for HCC in patients…